Sage Therapeutics, Inc. Financial Ratios — SAGE Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-317.19	-48.93	-59.3	-53.57	-57.81	-50.3	-66.79	37.37	-22.98	-33.49	-48.37	-56.06
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	40.49	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	100	94.18	99.95	91.23	89.42	97.5	77.1
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	-434.34	-10,277.24	56.24	-7,240.44	-7,102.09	-630.47	-992.86
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-435.61	-10,310.48	56	-7,306.74	-7,116.69	-632.08	-995.36
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	120.3	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	-413.06	-9,904.46	54.4	-7,258.91	-6,931.88	-626.32	-971.48
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-413.06	-9,904.46	54.4	-7,258.91	-6,931.88	-626.32	-971.48
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	-413.06	-9,904.46	54.4	-7,258.91	-6,931.88	-626.32	-971.48
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	0.04	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Total Debt	- -	- -	- -	- -	- -	- -	- -	37	28	18	12	5	12
ST Debt	- -	- -	- -	- -	- -	- -	- -	10	9	7	8	5	1
LT Debt	- -	- -	- -	- -	- -	- -	- -	27	19	11	4	- -	11
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.05	0.04	-0.04	-0.02	-0.01	-0.03
Net Debt/EBITDA	0.29	0.44	3.78	1.98	1.05	1.12	0.49	0.18	-2.65	0.64	0.3	0.13	0.2
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.05	0.05	-0.04	-0.02	-0.01	-0.03
Net Debt/EBIT	0.29	0.44	3.78	1.97	1.05	1.12	0.49	0.18	-2.66	0.64	0.3	0.13	0.2
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-447.21	-371.25	-51.55	-85.36	-79.18	-111.42	-101.11	-151.6	-48.05	-81.93	-149.52	-291.25	-542.8
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	2.84	0.94	0.63	0.36	- -	2.26
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-1.67	-1.93	-0.74	-0.22	- -	-0.36
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	2.48	0.9	0.6	0.33	- -	1.92
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	3.93	1.36	1.07	0.97	0.65	2.54
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-2.31	-2.78	-1.25	-0.6	-0.2	-0.4
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	3.42	1.3	1.01	0.89	0.59	2.16
Net Debt to Equity	20.92	25.58	-104.83	-107.52	-45.73	-64.41	-22.13	-13.41	-80.16	-17.02	-12.99	-8.88	-17.42
Net Debt/Capital (%)	17.3	20.3	65.65	53.65	34.47	34.15	16.54	7.31	62.2	16.61	7.47	2.69	2.67
EBITDA	-10	-18	-34	-95	-160	-273	-392	-706	627	-457	-546	-545	-409
EBITDA-CapEx	-10	-18	-34	-95	-161	-274	-395	-712	626	-457	-547	-546	-409
Operating Income (Loss)	-10	-18	-34	-95	-160	-273	-393	-708	624	-461	-547	-546	-411

Liquidity (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Cash Ratio	1.97	3.48	16.47	12.2	11.3	9.99	10.73	8.99	31.24	20.45	12.82	9.1	7.04
Current Ratio	1.99	3.63	16.61	12.31	11.45	10.11	10.98	9.23	31.58	21.14	13.47	10.51	7.42
Quick Ratio	1.97	3.48	16.47	12.2	11.3	9.99	10.73	8.99	31.24	20.67	12.96	10.11	7.17
CFO/Avg Current Liab	- -	-9.38	-5.37	-6.13	-4.7	-5.03	-3.78	-5.34	7.41	-4.96	-4.99	-5.94	-3.46
Common Equity/Total Assets	-447.21	-371.25	-51.55	-85.36	-79.18	-111.42	-101.11	-151.6	-48.05	-81.93	-149.52	-291.25	-542.8
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	2.84	0.94	0.63	0.36	- -	2.26
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-1.67	-1.93	-0.74	-0.22	- -	-0.36
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	2.48	0.9	0.6	0.33	- -	1.92
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	3.93	1.36	1.07	0.97	0.65	2.54
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-2.31	-2.78	-1.25	-0.6	-0.2	-0.4
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	3.42	1.3	1.01	0.89	0.59	2.16
CFO/Total Liabilities	-54.46	-43.72	-347.58	-461.33	-329.53	-402.62	-290.49	-379.01	764.31	-392.89	-442.98	-653.3	-325.32
CFO/CapEx	-80.41	-5,838.67	-211.27	-356.97	-83.52	-161.23	-91.14	-91.93	1,925.45	-1,016.62	-490.97	-977.55	- -
Altman's Z-Score	-16.31	-11.41	60.43	61.67	27.17	66.97	27.94	12.53	32.98	14.71	10.75	4.45	-6.58

Working Capital (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	0.02	0.06	0.08	0.06	0.15	0.82
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	22,494.04	6,123.28	4,666.79	6,599.63	2,474.02	444.79
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	-22,494.04	-6,123.28	-4,666.79	-6,599.63	-2,474.02	-444.79
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Market Capitalization	- -	- -	790	1,619	1,710	6,278	4,418	3,670	4,497	2,496	2,262	1,297	330
- Cash & Cash Equivalents	3	8	128	187	169	306	191	127	1,661	294	163	71	81
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	37	28	18	12	5	12
Enterprise Value	-3	-8	662	1,433	1,313	5,759	3,495	2,698	2,426	772	1,002	549	-163
Total Capital	-13	-32	-67	-161	-320	-590	-963	-1,606	-1,009	-1,477	-2,016	-2,564	-2,958
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-2.31	-2.78	-1.25	-0.6	-0.2	-0.4
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	0.01	0.01	0.02	0.01	0.01	-0.07
EV/Sales	- -	- -	- -	- -	- -	- -	38.72	392.89	2.18	122.38	130.31	6.35	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	3.87	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	3.89	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	3.65	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	3.65	- -	- -	- -	- -
Diluted Market Cap	- -	- -	790	1,619	1,710	6,278	4,418	3,670	4,585	2,496	2,262	1,297	330
Diluted Enterprise Value	-3	-8	662	1,433	1,542	5,971	4,227	3,580	2,952	2,220	2,111	1,231	261
EV per Share	- -	- -	30.68	51.58	39.19	151.1	75.78	53.08	46.66	13.16	16.89	9.17	- -
TTM Sales	- -	- -	- -	- -	- -	- -	90	7	1,114	6	8	86	41
TTM EBITDA	-10	-18	-34	-95	-160	-273	-392	-706	627	-457	-546	-545	-409
TTM Operating Income	-10	-18	-34	-95	-160	-273	-393	-708	624	-461	-547	-546	-411
TTM Cash Flow to Firm	-9	-18	-27	-71	-119	-219	-261	-529	664	-378	-460	-541	-267
TTM Free Cash Flow to Firm	-9	-18	-27	-70	-117	-218	-258	-523	665	-378	-459	-540	-267

Multiples (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Price/Free Cash Flow	- -	- -	-29.34	-22.98	-14.58	-28.81	-17.14	-7.02	6.9	-6.61	-4.93	-2.4	-1.23
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	3.89	- -	- -	- -	- -
Enterprise Value	-3	-8	662	1,433	1,313	5,759	3,495	2,698	2,426	772	1,002	549	-163
Low Price	- -	- -	24.25	35	26.28	44.55	79.88	56.5	25.01	36.13	27.36	16.51	4.62
EV/Sales	- -	- -	- -	- -	- -	- -	38.72	392.89	2.18	122.38	130.31	6.35	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	3.87	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	7.42	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-21.41	-16.08	-8.24	-10.82	-18.41	-11.32	4.69	-7.66	-4.12	-3.9	-1.92
Price/Earnings High	- -	- -	-28.7	-26.17	-12.26	-24.46	-24.24	-14.46	7.77	-12.61	-5.09	-6.63	-4.29
Price/Earnings Low	- -	- -	-15.47	-10.29	-5.54	-6.29	-9.88	-4.22	2.15	-4.63	-3.05	-1.82	-0.7
Price/Book Value	- -	- -	-11.81	-10.04	-5.34	-10.63	-4.59	-2.23	-4.33	-1.67	-1.12	-0.5	-0.11
Price/Book Value Average	- -	- -	-10.83	-9.42	-4.09	-4.95	-7.13	-4.68	-2.74	-2.35	-1.08	-0.82	-0.26
Price/Book Value High	- -	- -	-14.52	-15.33	-6.09	-11.19	-9.38	-5.99	-4.54	-3.86	-1.34	-1.4	-0.58
Price/Book Value Low	- -	- -	-7.83	-6.03	-2.75	-2.88	-3.82	-1.75	-1.25	-1.42	-0.8	-0.38	-0.09
Price/Tangible Book Value	- -	- -	6.48	9.32	4.64	13.2	5.12	3.88	2.17	1.44	1.81	1.62	0.71
Price/Tangible Book Value Average	- -	- -	5.94	8.75	3.55	6.15	7.96	8.15	1.37	2.03	1.75	2.64	1.65
Price/Tangible Book Value High	- -	- -	7.96	14.24	5.29	13.9	10.47	10.42	2.27	3.34	2.17	4.49	3.69
Price/Tangible Book Value Low	- -	- -	4.29	5.6	2.39	3.57	4.27	3.04	0.63	1.23	1.3	1.24	0.6
Price/Sales	- -	- -	- -	- -	- -	- -	48.94	534.32	4.04	395.66	294.29	15	8
Price/Sales Average	- -	- -	- -	- -	- -	- -	76.05	1,120.88	2.55	556.18	285.55	24.41	18.66
Price/Sales High	- -	- -	- -	- -	- -	- -	100.12	1,432.64	4.23	915.12	352.94	41.52	41.64
Price/Sales Low	- -	- -	- -	- -	- -	- -	40.81	418.19	1.17	336.04	211.11	11.43	6.81
Price/Cash Flow	- -	- -	-29.2	-22.91	-14.41	-28.63	-16.95	-6.94	6.77	-6.6	-4.92	-2.4	-1.23
Price/Cash Flow Average	- -	- -	-26.77	-21.5	-11.04	-13.32	-26.34	-14.56	4.28	-9.28	-4.77	-3.9	-2.88
Price/Cash Flow High	- -	- -	-35.89	-34.99	-16.43	-30.13	-34.67	-18.61	7.09	-15.26	-5.9	-6.64	-6.43
Price/Cash Flow Low	- -	- -	-19.35	-13.76	-7.42	-7.74	-14.13	-5.43	1.96	-5.61	-3.53	-1.83	-1.05
Price/Free Cash Flow Average	- -	- -	-26.9	-21.56	-11.17	-13.41	-26.63	-14.72	4.36	-9.29	-4.78	-3.91	-2.88
Price/Free Cash Flow High	- -	- -	-36.06	-35.09	-16.63	-30.32	-35.06	-18.81	7.22	-15.28	-5.91	-6.65	-6.43
Price/Free Cash Flow Low	- -	- -	-19.44	-13.79	-7.51	-7.79	-14.29	-5.49	1.99	-5.61	-3.53	-1.83	-1.05
EV/Sales Average	- -	- -	- -	- -	- -	- -	73.93	1,107.84	1.09	512.46	265.96	23.65	16.98
EV/Sales High	- -	- -	- -	- -	- -	- -	98.01	1,419.6	2.76	871.4	333.35	40.76	39.96
EV/Sales Low	- -	- -	- -	- -	- -	- -	38.7	405.14	- -	292.32	191.52	10.67	5.13
EV/EBITDA Average	0.29	0.44	-17.66	-14.1	-7.14	-9.59	-17.02	-10.78	1.93	-7.08	-3.74	-3.75	-1.71
EV/EBITDA High	0.29	0.44	-24.96	-24.19	-11.14	-23.11	-22.56	-13.81	4.91	-12.04	-4.69	-6.46	-4.02
EV/EBITDA Low	0.29	0.44	-11.71	-8.31	-4.45	-5.1	-8.91	-3.94	-0.53	-4.04	-2.7	-1.69	-0.52
EV/EBIT Average	0.29	0.44	-17.63	-14.08	-7.13	-9.58	-16.97	-10.74	1.94	-7.01	-3.74	-3.74	-1.71
EV/EBIT High	0.29	0.44	-24.92	-24.16	-11.12	-23.07	-22.5	-13.77	4.93	-11.93	-4.68	-6.45	-4.01
EV/EBIT Low	0.29	0.44	-11.7	-8.3	-4.44	-5.1	-8.88	-3.93	-0.53	-4	-2.69	-1.69	-0.52
Last Price	- -	- -	36.6	58.3	51.06	164.71	95.79	72.19	86.51	42.54	38.14	21.67	5.43
High Price	- -	- -	44.98	89.04	58.22	173.36	195.97	193.56	90.58	98.39	45.74	59.99	28.26
Enterprise Value Average	-3	-8	596	1,333	1,141	2,616	6,674	7,609	1,210	3,233	2,044	2,045	700
Enterprise Value High	-3	-8	843	2,287	1,781	6,301	8,847	9,750	3,076	5,497	2,562	3,524	1,648
Enterprise Value Low	-3	-8	395	785	712	1,392	3,493	2,782	-333	1,844	1,472	922	212

Shares Outstanding	25	25	26	29	37	42	47	52	58	59	60	60	61
Diluted Weighted Avg Shares	17	17	22	28	33	38	46	51	53	59	59	60	61
Basic Weighted Avg Shares	17	17	22	28	33	38	46	51	52	59	59	60	61
Revenue per Share	- -	- -	- -	- -	- -	- -	1.96	0.14	21.43	0.11	0.13	1.44	0.68
EBITDA per Share	-0.57	-1.09	-1.56	-3.4	-4.77	-7.15	-8.5	-13.89	12.05	-7.78	-9.2	-9.11	-6.74
Operating Income per Share	-0.57	-1.09	-1.57	-3.41	-4.78	-7.17	-8.53	-13.93	12	-7.86	-9.22	-9.13	-6.76
Basic EPS, GAAP	-0.57	-1.09	-1.57	-3.4	-4.75	-7.09	-8.08	-13.38	11.66	-7.8	-8.98	-9.05	-6.59
Basic EPS from Cont Ops	-0.57	-1.09	-1.57	-3.4	-4.75	-7.09	-8.08	-13.38	11.66	-7.8	-8.98	-9.05	-6.59
Diluted EPS, GAAP	-0.57	-1.09	-1.57	-3.4	-4.75	-7.09	-8.08	-13.38	11.43	-7.8	-8.98	-9.05	-6.59
Diluted EPS from Cont Ops	-0.57	-1.09	-1.57	-3.4	-4.75	-7.09	-8.08	-13.38	11.43	-7.8	-8.98	-9.05	-6.59
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.53	-1.04	-1.25	-2.54	-3.54	-5.75	-5.65	-10.4	12.78	-6.45	-7.76	-9.03	-4.4
Free Cash Flow per Basic Share	-0.54	-1.04	-1.26	-2.55	-3.59	-5.79	-5.71	-10.51	12.77	-6.45	-7.77	-9.04	-4.4
Cash & Equivalents per Share	0.17	0.48	5.92	6.72	11.87	13.61	20.01	19.84	40.39	29.7	21.46	12.59	8.3
Book Value per Share	-0.8	-1.89	-3.1	-5.81	-9.56	-15.49	-20.89	-32.33	-19.96	-25.49	-34.2	-42.94	-48.88
Tangible Book Value per Share	-0.8	-1.88	5.65	6.25	11	12.48	18.71	18.58	39.87	29.47	21.12	13.36	7.65

Sage Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)